Skip to main content
SpringerLink
Log in

Congestive cardiac failure: advances in management

  • Symposium: Pediatric Cardiology
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Francis GS. Neurohumoral mechanisms involved in congestive heart failure.Am J Cardiol 1985;55: 15A-21A

    Article  PubMed  CAS  Google Scholar 

  2. Mancini DM, LeJemtel TH, Factor S, Sonnenblick EH. Central and peripheral components of cardiac failure.Am J Med 1986;80 Suppl 28 2–13

    Article  PubMed  CAS  Google Scholar 

  3. Needleman P, Greenwald JE. Atrio-Peptin: A cardiac hormone intimately involved in fluid, electrolyte and blood-pressure homeostasis.New Engl J Med 1986;314 : 828–834

    Article  PubMed  CAS  Google Scholar 

  4. Raine AEG,Erne P, Burgisser E, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure.New Engl J Med 1986;315: 533–7

    Article  PubMed  CAS  Google Scholar 

  5. Collucci WS, Wright RF, Braunwald E. New positive ionotropic agents in the treatment of congestive heart failure (Part 1)New Engl J Med 1986;314: 290–299

    Article  Google Scholar 

  6. Collucci WS, Wright RF, Braunwald E. New positive ionotropic agents in the treatment of congestive heart failure (Part 2)New Engl J Med 1986;314: 349–358

    Article  Google Scholar 

  7. LeJemtel TH, Sonnenblick EH. Should the failing heart be stimulated?New Engl J Med 1984;310: 1384–1385

    Article  PubMed  CAS  Google Scholar 

  8. Katz AM. A new inotropic agent, its promise and a caution.New Engl J Med 1978;299: 1409–10

    Article  PubMed  CAS  Google Scholar 

  9. Ruffolo RR Jr, Kopia GA. Importance of receptor regulation in the Pathophysiology and treatment of congestive heart failure.Am J Med 1986;80 (Suppl II B) 67–72

    Article  PubMed  Google Scholar 

  10. Kaplan S. New aspects of management of congestive heart failure in Pediatric cardiovascular diseases. Mary Allen Engl ed. Philadelphia: FA Davis Company, 293–299

  11. Isalo E and Dahl M. Serum levels and renal excretion of digoxin during maintainence therapy in childrenActa Pediatr Scand 1974;63: 699–704

    Article  Google Scholar 

  12. Goroodischer R, Jusko WJ, Yaffe EJ. Tissue and erythrocyte distribution of digoxin in infants.Clin Pharmacol Ther 1976;19: 256–263

    Google Scholar 

  13. Selzer A. Digitalis in cardiac failure: Do benefits justify risks.Arch Int Med 1981;141 : 18–19

    Article  CAS  Google Scholar 

  14. Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JM. Digitalis glycosides: Mechanisms and manifestations of toxicity.Prog Cardiovasc Dis 1984;27 : 21–40

    Article  PubMed  CAS  Google Scholar 

  15. Wenger TL, Butler VP Jr, Haber E et al. Treatment of 63 severely digitalis toxic patients with digoxin specific antibody fragments.J Am Coll Cardiol 1985;5:118A-123A

    Article  PubMed  CAS  Google Scholar 

  16. Liang C, Sherman LG, Doherty JU, Wellington K, Lee VW, Hood WB Jr. Sustained improvement of cardiac function in patients with congestive heart failure after short term infusion of dobutamine.Circulation 1984;69: 113–119

    PubMed  CAS  Google Scholar 

  17. Massie B, Bourassa M, DiBianco R, et al. Long term oral administration of amrinone for congestive heart failure-lack of efficacy in a multicenter controlled trial.Circulation 1985;71: 963–71

    PubMed  CAS  Google Scholar 

  18. Maclean W, Tudhope GR. Modern diuretic therapy.Br Med J 1983;286: 1419–1422

    Article  CAS  Google Scholar 

  19. Levine TB. Role of vasodilators in the treatment of congestive heart failure.Am J Cardiol 1985;55: 32A-35A

    Article  PubMed  CAS  Google Scholar 

  20. Sutton FJ. Vasodilator therapy.Am J Med 1986; Suppl 2B80: 54–58

    Article  PubMed  CAS  Google Scholar 

  21. Guiha NH, Colin JN, Nikulic F, Franciosa JA, Limas CJ. Treatment of refractory heart failure with infusion of nitroprusside.New Engl J Med 1974;291: 587–592

    Article  PubMed  CAS  Google Scholar 

  22. Chatterjee K, Parmley WW, Massie B, Greenberg B, et al. Oral hydrallazine therapy for chronic refractory heart failure.Circulation 1976;54: 879–883

    PubMed  CAS  Google Scholar 

  23. Baughman KL. Calcium channel blocking agents in congestive heart failure.Am J Med 1986; Suppl 2B80: 46–50

    Article  PubMed  CAS  Google Scholar 

  24. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification d by converting enzyme inhibition in patients with severe heart failure.Circulation 1986;73: 257–267

    PubMed  CAS  Google Scholar 

  25. Packer M. Converting enzyme inhibition for severe chronic heart failure.Int J Cardiol 1985;7: 111–120

    Article  PubMed  CAS  Google Scholar 

  26. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administrative Cooperative study.New Engl J Med 1986;314: 1547–1552

    Article  PubMed  CAS  Google Scholar 

  27. Alderman J, Grossman W. Are beta-blocking drugs useful in the treatment of dilated cardiomyopathy.Circulation 1985;71: 854–857

    PubMed  CAS  Google Scholar 

  28. Fisher ML, Plotnick GD, Peters RW, Carliner NH. Beta blockers in congestive cardiomyopathy. Conceptual advance or contradiction ?Am J Med 1986; Suppl 2B80: 59–66

    Article  PubMed  CAS  Google Scholar 

  29. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Beneficial effects of long term beta blockade in congestive cardiomyopathy.Br Heart J 1980;44: 117–133

    Article  PubMed  CAS  Google Scholar 

  30. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.Br Heart J 1980:44: 134–142

    Article  PubMed  CAS  Google Scholar 

  31. Waagstein F, Hjalmarson A, Wallentin I. Hemodynamic effects of chronic beta-blockade in dilated cardiomyopathy (Abstr.)J Am Coll Cardiol 1985;5: 441

    Google Scholar 

  32. Engelmeier RS, O’Connell JB, Walsh R, et al. Metoprolol in dilated cardiomyopathy: Improved exercise tolerance with chronic therapy (Abstr).Circulation 1984;70 (Suppl II) : II-117

    Google Scholar 

  33. Anderson JL, Lutz JR Gilbert EM, et al. A randomised trial of low dose beta blockade in congestive cardiomyopathy.Am J Cardiol 1985;55: 471–475

    Article  PubMed  CAS  Google Scholar 

  34. Hamer J. Modern management of congestive heart failure.Recent advances in cardiology 1984;9: 275–288

    Google Scholar 

  35. Friedmen WF and George BL. New concepts and drugs in the treatment of congestive heart failure.Pediatr Clin North Am 1984;31: 1197–1227

    Google Scholar 

  36. Tandon R. Congestive cardiac failure. In:Current trends in Pediatrics. M.Singh ed. Delhi; Vanity Books 1986 p 115–124

    Google Scholar 

  37. Kereikas DJ, Parmley WW. Myocarditis and Cardiomyopathy.Am Heart J 1984;108: 1318–1326

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, All India Institute of Medical Sciences, New Delhi

    V. Dev &  R. Tandon (Professor of Cardiology)

Authors
  1. V. Dev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Tandon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dev, V., Tandon, R. Congestive cardiac failure: advances in management. Indian J Pediatr 55, 15–26 (1988). https://doi.org/10.1007/BF02722555

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02722555

Keywords

Search

Navigation